Surface-treated catheters--a review.

abstract：:Appropriate antibiotic dosing in critically ill, infected, patients receiving continuous renal replacement therapy (CRRT) is crucial to improve patient outcomes. Severe sepsis and septic shock result in changes in pharmacokinetic parameters, including increased volume of distribution, hypoalbuminemia, and changes in r...

journal_title：Seminars in dialysis

authors： Shaw AR,Chaijamorn W,Mueller BA

更新日期：2016-07-01 00:00:00

abstract：:We present a case of arteriovenous graft pseudoaneurysms treated endovascularly with stent grafts and make suggestions regarding the technique of evaluating the pseudoaneurysms and choosing the proper location to deploy the stent grafts to maximize the outcomes and minimize the length of the graft covered by the stent...

journal_title：Seminars in dialysis

authors： Florescu MC,Fillaus JA,Plumb TJ

更新日期：2014-03-01 00:00:00

abstract：:The profile of patients on chronic dialysis has shifted. There is a growing group of older patients with comorbid dementia and ESKD, who are at risk of overuse, underuse, and misuse of dialysis. Policy is lacking to help guide treatment decisions in this group. This paper explores clinical considerations specific to p...

journal_title：Seminars in dialysis

authors： MacPhail A,Ibrahim JE,Fetherstonhaugh D,Levidiotis V

更新日期：2015-09-01 00:00:00

abstract：:Dialysis is measured as Kt/V, which scales the dose (Kt) to body water content (V). Scaling dialysis dose to body surface area (S(dub)) has been advocated, but the implications of such rescaling have not been examined. We developed a method of rescaling measured Kt/V to S(dub) and studied the effect of such alternativ...

journal_title：Seminars in dialysis

authors： Daugirdas JT,Depner TA,Greene T,Kuhlmann MK,Levin NW,Chertow GM,Rocco MV

更新日期：2008-09-01 00:00:00

abstract：:Extracorporeal elimination of drugs and toxins is a critical component in the management of poisonings, though specific techniques and indications remain a matter of debate. Conventional hemodialysis is frequently the treatment of choice because of its widespread availability and proven effectiveness for certain drugs...

journal_title：Seminars in dialysis

authors： Goodman JW,Goldfarb DS

更新日期：2006-09-01 00:00:00

abstract：:There are studies reporting that soluble kltho (sKlotho) deficiency plays a role in cardiovascular disease in addition to traditional risk factors such as diabetes, hypertension, anemia, smoking, and excessive volume burden. Our aim in this study was to investigate the relationship of sKlotho with uremic cardiomyopath...

journal_title：Seminars in dialysis

authors： Erkus E,Buyukterzı Z,Karakose S,Kurku H,Kurtgoz PO,Topal M,Guney I

更新日期：2020-11-30 00:00:00

abstract：:There is clear evidence that survival rates following transplantation far exceed those for remaining on dialysis, regardless of body size measured by body mass index (BMI). Studies over the past 15 years also suggest little to no difference in long-term outcomes, including graft survival and mortality, irrespective of...

journal_title：Seminars in dialysis

authors： MacLaughlin HL,Campbell KL

更新日期：2019-05-01 00:00:00

abstract：:The risk of intradialytic hypotension (IDH) is determined by various factors, among them dialysis modality and dialyzer membrane. We conducted a literature search in PubMed on November 1, 2016 and selected relevant randomized controlled and cross-over trials, and prospective and retrospective cohort studies published ...

journal_title：Seminars in dialysis

authors： Patel S,Raimann JG,Kotanko P

更新日期：2017-11-01 00:00:00

abstract：:This report reviews the most common surgical interventions and complications of chronic peritoneal dialysis (PD) patients. Based on the current knowledge as well as our experience we detail the role of these surgical procedures. We supplement the reported knowledge in the field with our own experience in this area. Th...

journal_title：Seminars in dialysis

authors： Ratajczak A,Lange-Ratajczak M,Bobkiewicz A,Studniarek A

更新日期：2017-01-01 00:00:00

abstract：:Anemia is a common complication of advanced chronic kidney disease (CKD). Treatment with erythropoiesis-stimulating agents (ESAs) remains a common approach in managing anemia of CKD. The 2012 Kidney Disease Improving Global Outcomes Clinical Practice Guideline for Anemia in CKD suggests avoiding ESA therapy use to mai...

journal_title：Seminars in dialysis

authors： Shah HH,Fishbane S

更新日期：2018-07-01 00:00:00

abstract：:Catheter malfunction due to poor flow is a common problem. When it occurs early, the cause is generally technical. Late occurrences are most often related to thrombus formation. Several types of thrombus may be seen, differing by location and supposed mechanism of formation. The most common offender, however, is the f...

journal_title：Seminars in dialysis

authors： Beathard GA

更新日期：2001-11-01 00:00:00

abstract：:Catheter recirculation (CR) occurs when blood returning from the venous limb of the catheter re-enters the arterial limb of the catheter without passage through the circulation. Adequacy of dialysis is influenced by the degree of access recirculation. In this study we evaluate factors influencing the degree of dialysi...

journal_title：Seminars in dialysis

authors： Moossavi S,Vachharajani TJ,Jordan J,Russell GB,Kaufman T,Moossavi S

更新日期：2008-05-01 00:00:00

abstract：:Few elderly patients with end-stage renal disease (ESRD) are treated with peritoneal dialysis (PD). Among dialysis patients >or=65 years of age reported by the U.S. Renal Data System (USRDS), the percentage treated with chronic peritoneal dialysis (CPD) is lower than in any other age group. To evaluate the effectivene...

journal_title：Seminars in dialysis

authors： Kadambi P,Troidle L,Gorban-Brennan N,Kliger AS,Finkelstein FO

更新日期：2002-11-01 00:00:00

abstract：:Coping with the transition from end-stage kidney disease to dialysis can be challenging for patients and their care partners. Introducing incident dialysis patients to incremental forms of dialysis is associated with better quality of life and reduced cost. Incremental hemodialysis (HD) has generated significant inter...

journal_title：Seminars in dialysis

authors： Auguste BL,Bargman JM

更新日期：2018-09-01 00:00:00

abstract：:In patients receiving hemodialysis, the provision of safe and effective vascular access using an arteriovenous fistula or graft is regarded as a critical priority by patients and health professionals. Vascular access failure is associated with morbidity and mortality, such that strategies to prevent these outcomes are...

journal_title：Seminars in dialysis

authors： Viecelli AK,Mori TA,Roy-Chaudhury P,Polkinghorne KR,Hawley CM,Johnson DW,Pascoe EM,Irish AB

更新日期：2018-05-01 00:00:00

abstract：:Over 60% of patients initiating chronic hemodialysis in the United States have a chronic central venous catheter (CVC) as their first blood access device. Although it would be better if these patients started dialysis with fistulas, the CVC is used because it is a reliable and relatively safe method for obtaining bloo...

journal_title：Seminars in dialysis

authors： Ash SR

更新日期：2007-05-01 00:00:00

abstract：:Hemodialysis patients with failed upper extremity (arm) access sites comprise 5-10% of the dialysis population. In these patients, arm vessels are either unsuitable for access placement due to trauma or peripheral vascular disease, or have been exhausted following dialysis usage. Synthetic grafts in the lower extremit...

journal_title：Seminars in dialysis

authors： Abreo KD,Ram SJ

更新日期：2009-09-01 00:00:00

abstract：:Kidney transplantation is the treatment of choice for most patients with end-stage renal disease (ESRD), with success rates greater than were envisioned as recently as a decade ago. Unfortunately this trend has created unprecedented demand for transplantable organs and new challenges for those desiring transplantation...

journal_title：Seminars in dialysis

authors： Gaston RS

更新日期：2005-11-01 00:00:00

abstract：:Universal lower dialysate [Na+] is often advocated as a means of improving the dire cardiovascular plight of our dialysis patients. However, there is evidence associating lower dialysate [Na+] and increased morbidity and mortality especially in frailer patients, probably as a result of more frequent intra-dialytic hyp...

journal_title：Seminars in dialysis

authors： Marshall MR,Dunlop JL

更新日期：2012-05-01 00:00:00

abstract：:Cardiovascular morbidity and mortality remain frustratingly common in dialysis patients. A dearth of established evidence-based treatment calls for alternative therapeutic avenues to be embraced. Sympathetic hyperactivity, predominantly due to afferent nerve signaling from the diseased native kidneys, has been establi...

journal_title：Seminars in dialysis

authors： Hoye NA,Wilson LC,Jardine DL,Walker RJ

更新日期：2019-05-01 00:00:00

abstract：:Despite decades of research, there are few published guidelines related to the safety and efficacy of exercise training in hemodialysis patients. This has led to disparate recommendations regarding the type, intensity, and timing for exercise, especially for patients with multiple comorbidities. Many common recommenda...

journal_title：Seminars in dialysis

authors： Wilund KR,Jeong JH,Greenwood SA

更新日期：2019-07-01 00:00:00

abstract：:Cardiac hypertrophy is a relatively common complication seen in patients with advanced chronic kidney disease (CKD) and end-stage renal disease (ESRD). Moreover, cardiac hypertrophy is even more frequently seen in patients with ESRD who have an arteriovenous (AV) access. There has been substantial evidence pertaining ...

journal_title：Seminars in dialysis

authors： Duque JC,Gomez C,Tabbara M,Alfonso CE,Li X,Vazquez-Padron RI,Asif A,Lenz O,Briones PL,Salman LH

更新日期：2015-05-01 00:00:00

abstract：:Diabetes mellitus (DM) is a common and devastating disease, affecting up to 19.3 million Americans. It is the leading cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) in the United States. Diabetic patients with ESRD have a high incidence of cardiovascular disease and death. For those kidney tr...

journal_title：Seminars in dialysis

authors： Luan FL,Samaniego M

更新日期：2010-03-01 00:00:00

abstract：:Hyperkalemia is common in patients with end-stage renal disease, and may result in serious electrocardiographic abnormalities. Dialysis is the definitive treatment of hyperkalemia in these patients. Intravenous calcium is used to stabilize the myocardium. Intravenous insulin and nebulized albuterol lower serum potassi...

journal_title：Seminars in dialysis

authors： Putcha N,Allon M

更新日期：2007-09-01 00:00:00

abstract：:Managing an end-stage renal disease (ESRD) patient is complex and presents many ethical challenges for the physician. Ownership of dialysis facilities has shifted over the past decade from largely nonprofit organizations to large companies whose shareholders are primarily interested in the profitability of their inves...

journal_title：Seminars in dialysis

authors： Bennett WM

更新日期：2004-01-01 00:00:00

abstract：:The patency of the vascular access (VA) is a fight for the attending nephrologist. A retrospective observational study was conducted to compare the success rate of surgical versus endovascular technique percutaneous transluminal angioplasty (PTA) for graft thrombosis treatment. Of 3008 patients, 22.1% patients were di...

journal_title：Seminars in dialysis

authors： Ponce P,Carvalho T,Messias H,Neves F,Lisbon VAC Interventional Nephrology Team.

更新日期：2014-09-01 00:00:00

abstract：:Physical, psychosocial, and lifestyle disturbances, along with physical and emotional symptoms, have been shown to impact the health-related quality of life (HRQOL) of those dependent on renal replacement therapy. The value of HRQOL measurement as a tool to improve clinical care has been recognized by patients, clinic...

journal_title：Seminars in dialysis

authors： Unruh ML,Weisbord SD,Kimmel PL

更新日期：2005-03-01 00:00:00

abstract：:Cancer and kidney disease are linked by causality and comorbidities. Observational data show an increased risk of malignancy as renal function declines. Erythropoietin stimulating agents (ESAs), which are the cornerstone therapy for anemia patients with chronic kidney disease and cancer, are associated with increased ...

journal_title：Seminars in dialysis

authors： Latcha S

更新日期：2019-11-01 00:00:00

abstract：:Peritoneal dialysis (PD) is an underutilized form of renal replacement therapy. Recent data have emphasized that only 12% of end-stage renal disease (ESRD) patients are initiated on this form of therapy in the United States. Patients requiring PD have most often been referred to general surgeons for catheter placement...

journal_title：Seminars in dialysis

authors： Asif A,Byers P,Gadalean F,Roth D

更新日期：2003-05-01 00:00:00

abstract：:Secondary hyperparathyroidism almost universally accompanies end-stage renal disease (ESRD). In some, but not all studies, elevated serum parathyroid hormone (PTH) concentrations are associated with increased fracture rates, cardiovascular disease, and mortality in ESRD. The serum concentration of PTH required for opt...

journal_title：Seminars in dialysis

authors： Zand L,Kumar R

更新日期：2016-05-01 00:00:00